NCT06953908

Brief Summary

The goal of this observational study is to systematically collect data on adults seeking medical and surgical treatments for gender incongruence. This prospective, longitudinal cohort aims to generate insights into the safety, effectiveness, and overall satisfaction with current treatments. Additionally, the study seeks to identify areas for improvement and support healthcare professionals in making informed decisions. Most importantly, it aims to enhance the quality of life for transgender and gender-diverse individuals by ensuring that the care they receive aligns with their needs and goals. Participants will include patients seeking treatment at the Copenhagen Center for Gender Identity, Denmark. Data collection will be both clinician- and patient-reported. Participants will be asked to complete online surveys at baseline, after the assessment process, and annually if they initiate hormone therapy. The study will systematically gather information on gender identity and transition experiences, sociodemographics, self-medication, health status, self-reported quality of life, and treatment preferences. Additionally, detailed records of treatment courses and specific interventions will be collected from all involved healthcare providers across specialties. The study will evaluate the effects of different treatment options, both in the short and long term. It will explore how quality of life is associated with gender identity, transition, sociodemographics, lifestyle, and health, as well as assess the medical impact of various treatments, including counseling, hormone therapy, and surgery. Furthermore, the study will investigate the prevalence of side effects and complications related to treatment, as well as factors influencing treatment discontinuation, including cases of detransition. Finally, the project will focus on quality indicators such as waiting times and patient satisfaction, contributing to the ongoing development of high-quality, patient-centered care for transgender and gender-diverse individuals.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
70mo left

Started Feb 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Feb 2022Jan 2032

Study Start

First participant enrolled

February 1, 2022

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

April 3, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 1, 2025

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2032

Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

10 years

First QC Date

April 3, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

Gender IdentityGender Incongruence

Outcome Measures

Primary Outcomes (1)

  • Assessment of quality of life

    The study uses the WHOQOL-BREF to assesses quality of life (QOL). The repeated assessment provides a snapshot of quality of life, allowing for the exploration of associations with other factors. The WHOQOL-BREF is scored from 0-100, with higher values indicating increased quality of life. Change from baseline in the four domains (Physical Helath, Psychological, Relationships, Environment) to the latest recorded yearly assessment recorded within the study period (10 years from 2022-2032)

    Baseline and latest yearly assessment.

Study Arms (1)

Adults seeking help regarding gender incongruence

All patients referred to The Center of Gender Identity in Copenhagen (CGI), 18 years or older, seeking medical og surgical treatment for gender incongruence.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants must be deemed eligible for assessment at The Center for Gender Identity in Copenhagen.

You may qualify if:

  • All patients referred to The Center for Gender Identity in Copenhagen

You may not qualify if:

  • Inability to read and understand Danish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Center for Gender Identity

Copenhagen, Denmark

RECRUITING

MeSH Terms

Conditions

Gender Dysphoria

Condition Hierarchy (Ancestors)

Sexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research associate

Study Record Dates

First Submitted

April 3, 2025

First Posted

May 1, 2025

Study Start

February 1, 2022

Primary Completion (Estimated)

January 31, 2032

Study Completion (Estimated)

January 31, 2032

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Sharing of individual participant data (IPD) is in conflict with Danish GDPR regulations, as it involves the transfer of personal and potentially sensitive information, which is restricted under Danish data protection laws to safeguard individuals' privacy and ensure compliance with strict legal and ethical requirements.

Locations